Breastfeeding, Exposure to Organochlorine Compounds, and Neurodevelopment in Infants

Núria Ribas‐Fitó, Esther Cardo, María Sala, +6

PEDIATRICS

Neurofeedback and standard pharmacological intervention in ADHD: A randomized controlled trial with six-month follow-up

Victoria Meisel, Mateu Servera, Gloria García‐Banda, +2

Biological Psychology

BiofeedbackAdhdPsychiatryBehavioral NeuroscienceMedicine +9

Association of Hexachlorobenzene and Other Organochlorine Compounds with Anthropometric Measures at Birth

Núria Ribas‐Fitó, María Sala, Esther Cardo, +6

Pediatric Research

Body CompositionAnthropometric MeasuresEarly Life ExposureDevelopmental ToxicologyPhysiology +6

Efficacy and Safety of Lisdexamfetamine Dimesylate and Atomoxetine in the Treatment of Attention-Deficit/Hyperactivity Disorder: a Head-to-Head, Randomized, Double-Blind, Phase IIIb Study

Esther Cardo, Péter Nagy, Colleen Anderson, +7

CNS Drugs

Distinctions Between Sluggish Cognitive Tempo, ADHD-IN, and Depression Symptom Dimensions in Spanish First-Grade Children

G. Leonard Burns, Mateu Servera, María del Mar Bernad, +2

Journal of Clinical Child & Adolescent Psychology

Children With Stroke: Polymorphism of the MTHFR Gene, Mild Hyperhomocysteinemia, and Vitamin Status

Esther Cardo, Eugènia Monrós, Catrina Colomé, +4

Journal of Child Neurology

Genetic EpidemiologyHuman PolymorphismHyperlipidemiaMthfr GeneMetabolic Syndrome +19

Anti-Epileptic drug treatment in children: Hyperhomocysteinaemia, B-Vitamins and the 677C→T Mutation of the Methylenetetrahydrofolate Reductase Gene

Marina Vilaseca, Eugènia Monrós, Rafael Artuch, +4

European Journal of Paediatric Neurology

MedicineInherited Metabolic DiseaseAnti-epileptic Drug TreatmentMethylenetetrahydrofolate Reductase GenePharmacology +1

Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-naïve children and adolescents with attention deficit/hyperactivity disorder

Alonso Montoya, Amaia Hervás, Esther Cardo, +6

Current Medical Research and Opinion

Evaluation of Patients' and Parents' Quality of Life in a Randomized Placebo-Controlled Atomoxetine Study in Attention-Deficit/Hyperactivity Disorder

Rodrigo Escobar, Alonso Montoya, Pepa Polavieja, +3

Journal of Child and Adolescent Psychopharmacology

Construct Validity of ADHD/ODD Rating Scales: Recommendations for the Evaluation of Forthcoming DSM-V ADHD/ODD Scales

G. Leonard Burns, James A. Walsh, Mateu Servera, +3

Journal of Abnormal Child Psychology

AdhdDsm-v Adhd/odd ScalesPsychiatryPsychologyAutism +6